跳至主要内容
临床试验/NCT03536975
NCT03536975已完成不适用

Pilot Study to Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases Including Persons Living With Mild Cognitive Impairment or Mild to Moderate Dementia and Their Primary Caregivers

University Hospital, Rouen2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2017年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
48
试验地点
2
主要终点
Burden of primary caregivers

研究概览

简要总结

Our main goal is to test a web platform accessible by computers, smartphones and tablets, addressed specifically to caregivers and people with mild cognitive deterioration or mild to moderate dementia providing added value services based on social networks, adapted interventions, clinic strategies and gamification to improve the quality of life of caregivers and people living with dementia (dyads) and permitting to leave in the community as long as possible.

To evaluate the platform effectiveness and impact in dementia type disease affected people and caregivers a randomized, controlled, parallel, longitudinal is proposed. The objective will be to assess during 18 months aspects related to health of individuals (general aspect of health, neuropsychological, daily living functionalities, quality of life, treatment adherence, comorbidities ...), social aspects (improving dyad relationship…) and economics (cost-effectiveness of platform utilization), as well as satisfaction degree and usability of platform.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For patients People, aged 50 and over, living in the community, who are able to give informed consent.
  • Diagnosed with mild cognitive impairment (MCI) according to Petersen criteria or mild to moderate dementia diagnosed according on DSM-IV criteria.
  • Having a Clinical Dementia Rating (CDR) of 0.5 for MCI, 1-2 for mild to moderate dementia Having a Mini-Mental Exam score (MMSE) between 30 and 25 (inclusive) for MCI, and between 24 and 10 (inclusive) for dementia.
  • Having a primary caregiver, familiar (or not), informal (or not) identified and also included in the study.
  • Be willing to use Information Technology and Communications (ICT) according to the investigator criteria.
  • Affiliated to the social security system.
  • For caregivers People, aged 18 years and over, with no diagnosis or no evidence of mild cognitive impairment or mild to moderate dementia (according DSM-IV criteria), who are able to give informed consent and with an intention to complete the study.
  • Primary caregivers, informal (or not), familiar (or not), of person with mild cognitive impairment or mild to moderate dementia People with Internet access and basic knowledge and skills in managing internet and social networks, or keen to learn, according to the investigator criteria Having a Geriatric Depression Scale (GDS-Yesavage - 15 items) score less than 11 at the time of entry into the trial indicating no severe depressive symptoms or for people < 50 years a MADRS < 15 Having no specific conditions (evaluated by the investigator) reducing their physical abilities below the norm for their age that would limit or impair CAREGIVERSPRO-MMD platform use.
  • Be willing to use Information Technology and Communications (ICT) according to the investigator criteria Affiliated to the social security system

排除标准

  • Terminal or severe illness with survival prognosis less than 18 months
  • Not speaking nor reading French
  • Enrolled in another clinical trial
  • For the patients : Having delusions, hallucinations, behavioural disturbances, that may interfere with the use of Information and Communications Technology (ICT) tools ; Under guardianship and/or under curatorship

研究组 & 干预措施

Platform

Other

Group with access to the web platform "CAREGIVERSPRO-MMD"

干预措施: Platform (Other)

Control

No Intervention

Group without any access to the web platform

结局指标

主要结局

Burden of primary caregivers

时间窗: 18 months

To evaluate the perceived burden of primary caregivers of persons living with mild cognitive impairment or mild to moderate dementia in order to identify a benefit from use of the CAREGIVERSPRO-MMD platform. The perceived burden will be evaluated by using a 29-item scale, Zarit Burden Interview (ZBI) rated from 0 to 88, 0 is a weak charge and more than 40 is a severe charge.

次要结局

  • Quality of life of patients(12 months)
  • Cognitive symptoms of patients(12 months)
  • Quality of life of caregivers(12 months)
  • Psychological symptoms of caregivers (2)(18 months)
  • Behavioural-psychological symptoms of patients (1)(18 months)
  • Perceived Social Support(18 months)
  • Relationships(18 months)
  • Behavioural-psychological symptoms of patients (2)(12 months)
  • Psychological symptoms of caregivers (1)(18 months)
  • Instrumental Activities of Daily Living(18 months)
  • Activities of Daily Living(6 months)
  • Quality of life of patients(6 months)
  • Quality of life of patients(18 months)
  • Quality of life of caregivers(6 months)
  • Cognitive symptoms of patients(18 months)
  • Cognitive symptoms of patients(6 months)
  • Psychological symptoms of caregivers (1)(6 months)
  • Psychological symptoms of caregivers (1)(12 months)
  • Psychological symptoms of caregivers (2)(6 months)
  • Psychological symptoms of caregivers (2)(12 months)
  • Instrumental Activities of Daily Living(6 months)
  • Instrumental Activities of Daily Living(12 months)
  • Activities of Daily Living(12 months)
  • Activities of Daily Living(18 months)
  • Behavioural-psychological symptoms of patients (1)(6 months)
  • Behavioural-psychological symptoms of patients (1)(12 months)
  • Behavioural-psychological symptoms of patients (2)(18 months)
  • Behavioural-psychological symptoms of patients (2)(6 months)
  • Perceived Social Support(6 months)
  • Perceived Social Support(12 months)
  • Relationships(6 months)
  • Relationships(12 months)

研究者

发起方
University Hospital, Rouen
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验